Physician profile
Nicholas Peter Mongillo
NPI 1073536710
$1,959.66
in general payments reported to CMS, 2019-2025
18 companies · $275 in 2025
The $275 reported for 2025 was more than what 82% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $133 · 2021: $52.03 · 2022: $352 · 2023: $575 · 2024: $313 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $493.43 | 2022-2025 | Azstarys |
| Tris Pharma INC | $473.06 | 2019-2025 | Dyanavel Xr, Onyda Xr |
| Ironshore Pharmaceuticals INC. | $174.08 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $116.61 | 2019-2025 | Vaxelis, Gardasil 9, M-M-R II |
| Sanofi Pasteur INC. | $110.17 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $89.12 | 2023-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $80.39 | 2020-2024 | Bexsero, Rotarix |
| Vertical Pharmaceuticals, LLC | $75.84 | 2019-2025 | Relexxii |
| Takeda Pharmaceuticals U.S.A., INC. | $74.17 | 2019-2022 | |
| Kaleo, INC. | $64.42 | 2019-2024 | Auvi-Q |
| Neos Therapeutics, LP | $47.74 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $43.34 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $24.57 | 2020 | |
| Alk-Abello, INC | $22.20 | 2025 | Neffy |
| Verrica Pharmaceuticals INC. | $21.41 | 2023 | Ycanth |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20.87 | 2024 | |
| Rhodes Pharmaceuticals L.P. | $14.12 | 2019 | |
| Shire North American Group INC | $14.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Mongillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.